Skyscape Web Viewer : The Johns Hopkins Manual of Gynecology and Obstetrics : Main Index

View All
Minor vestibular gland duct opening
Minoxidil
Mirabegron
See also Recurrent pregnancy loss Epidemiology and Definition-Recurrent Pregnancy Loss Etiologies-Recurrent Pregnancy Loss in polycystic ovarian syndrome
Misoprostol Early Pregnancy Loss in the First Trimester-First and Second Trimester Pregnancy Loss and Ectopic Pregnancy Management of Normal Labor and Delivery-Normal Labor and Delivery, Operative Delivery, and Malpresentations
Mitosis
Mitoxantrone
Mitral regurgitation (MR)
Mitral stenosis (MS)
Mitral valve prolapse
Mixed connective tissue disease
Mixed germ cell tumors
Contact dermatitis
Contact vulvitis
Continence pessaries
Continuous urinary incontinence
See also specific types breastfeeding and emergency (postcoital) Introduction : Contraception and Sterilization permanent (sterilization) postpartum tiers of effectiveness of
Contraction stress test (CST) Fetal Heart Tracing With Late Decelerations Methods of Fetal Assessment-Fetal Assessment Summary of Antenatal Testing
Copper intrauterine devices Emergency (Postcoital) Contraception-Contraception and Sterilization Highly Effective Contraceptive Methods-Contraception and Sterilization
Cornua, of uterus
Coronary artery disease (CAD)
Coronary heart disease (CHD) in menopause screening for
Corpus, uterine
Corpus luteum Phases of the Menstrual Cycle-The Menstrual Cycle Suggested Readings-The Menstrual Cycle
Corticosteroids, antenatal Preterm Labor-Preterm Labor and Preterm Prelabor Rupture of Membranes Preterm PRELABOR Rupture of Membranes-Preterm Labor and Preterm Prelabor Rupture of Membranes Suggested Readings-Preterm Labor and Preterm Prelabor Rupture of Membranes
Cortisol, excess levels of
Counseling in primary and preventive care in recurrent pregnancy loss
Cowden syndrome Risk Factors for Uterine Cancer-Cancer of the Uterine Corpus Screening-Cancer of the Uterine Corpus Specific Hereditary Gynecologic Cancer Syndromes-Hereditary Cancer Syndromes Surveillance and Risk-Reduction Considerations for Known Mutation Carriers
Craniopharyngioma
Creatinine clearance

NDX